Heart Health
Statin alternative lowers heart-related deaths
Research we're watching
- Reviewed by Christopher P. Cannon, MD, Editor in Chief, Harvard Heart Letter; Editorial Advisory Board Member, Harvard Health Publishing
For people who can't take statin drugs, a cholesterol-lowering drug called bempedoic acid (Nexletol) can also lower the risk of heart attacks and related problems, a new study shows.
Published July 11, 2023, in JAMA, the study included about 4,200 people with high LDL (bad) cholesterol who couldn't take statins because of side effects. Their average age was 68, and about two-thirds had diabetes. Participants were randomly assigned to take either bempedoic acid or a placebo. Over a follow-up period of about 40 months, those taking the drug were 30% less likely to die of a heart-related condition, have a heart attack or stroke, or need an artery-opening stent compared with the people who took placebos. Bempedoic acid reduced LDL levels by 21%.
To continue reading this article, you must log in.
Subscribe to Harvard Health Online for immediate access to health news and information from Harvard Medical School.
- Research health conditions
- Check your symptoms
- Prepare for a doctor's visit or test
- Find the best treatments and procedures for you
- Explore options for better nutrition and exercise
I'd like to receive access to Harvard Health Online for only $4.99 a month.
Sign Me UpAlready a member? Login ».
About the Author
Julie Corliss, Executive Editor, Harvard Heart Letter
About the Reviewer
Christopher P. Cannon, MD, Editor in Chief, Harvard Heart Letter; Editorial Advisory Board Member, Harvard Health Publishing
Disclaimer:
As a service to our readers, Harvard Health Publishing provides access to our library of archived content. Please note the date of last review or update on all articles.
No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.
